Morning Market Losers

Finisar

shares tumbled 23.56% to $19.30 after the company reported downbeat earnings for the fourth quarter and issued a weak profit forecast for the current quarter. OncoMed Pharmaceuticals

dropped 20.64% to $19.76 after the company voluntarily stopped enrollment for Phase 1 Vantictumab. Cesca Therapeutics

declined 16.39% to $1.48 after the company priced priced 7.53 million share offering at $1.55 per share. Oculus Innovative Sciences

fell 7.29% to $3.05 on Q4 results. The company's net income rose $9.9 million to $7.5 million in the quarter. TG Therapeutics

shares declined 7.26% to $8.18 after the company's TG-1101 in combination with Ibrutinib showed a 90% response rate in patients with previously treated CLL and MCL. Achillion Pharmaceuticals

dropped 4.10% to $6.55 after dropping 6.32% on Thursday.